Himadri Speciality Chemical Limited (HSCL) — Announcement

· NSE Neutral
📢 Key Event
ICRA confirms no deviation in utilization of preferential issue proceeds
💡 Investor Takeaway
Shareholders see no risk to capital deployment and full compliance with SEBI norms.

Himadri Speciality Chemical Limited disclosed that ICRA Limited's final Monitoring Agency report for Q1 FY2027 confirms no deviation in utilization of INR 341.8172 crores raised via fully convertible warrants, with proceeds used as per offer document for capital expenditure and general corporate purposes, and no delays or unfavorable events affecting project viability.

📄 View Original Announcement (PDF)

About Himadri Speciality Chemical Limited (HSCL)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹30,070.68 Cr P/E: 56.6

View full HSCL stock details →

📡 Get AI alerts when HSCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track HSCL — Free

📊 More HSCL filings

See all HSCL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when HSCL files new disclosures

Track HSCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track HSCL — Free

Free account · 2 AI queries/day